Drug Type Antibody |
Synonyms |
Target |
Mechanism PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malignant neoplasm of gastro-oesophageal junction | Preclinical | TH | 30 Nov 2022 | |
Lung Cancer | Discovery | TH | 30 Nov 2022 | |
Melanoma | Discovery | TH | 30 Nov 2022 |